Impact of apolipoprotein E ε4 and vascular disease on brain morphology in men from the NHLBI twin study

Charles DeCarli, T. Reed, B. L. Miller, P. A. Wolf, G. E. Swan, D. Carmelli

Research output: Contribution to journalArticle

84 Citations (Scopus)

Abstract

Background and Purpose - Apolipoprotein E ε4 genotype (ApoE4) has been associated with increased risk for cardiovascular disease morbidity or mortality. This appears to be mediated by an ApoE4-related increase in cardiovascular atherosclerosis. Given the similarities between risk factors for heart disease and risk factors for stroke, a positive association between ApoE4 and stroke would be expected. Since age-related brain atrophy and the extent of white matter hyperintensities (WMH) share similar risk factors, we examined the combined effect of ApoE4 and history of vascular disease on brain volume, WMH, and MRI evidence of stroke. Methods - Subjects were the surviving members of the National Heart, Lung, and Blood Institute Twin Study. This is a longitudinal study of the effects of cardiovascular disease risk factors in community-dwelling male veterans. The fourth and final examination of this cohort included cerebral MRI and was completed in 1997. Apolipoprotein E (ApoE) genotype, quantitative measures of brain volume, WMH, and the presence of stroke on MRI were obtained from the 396 participants in the final examination. The presence or absence of a history of coronary heart disease, cerebrovascular disease, peripheral arterial disease, and ApoE genotype were determined for each subject. Results - Of the 396 men, 88 (22%) had at least 1 ApoE4 allele. ApoE4 was not associated with differences in age or education. While the prevalence of vascular disease was generally greater in the ApoE4 group, this was only significant for coronary heart disease (29.8% in subjects without ApoE4 versus 40.7% in subject with ApoE4; P=0.03). ApoEA subjects had significantly smaller brain volumes (942.4±34.5 versus 952.2 ± 40.1 cm3; P= 0.02). MRI evidence of stroke was detected in 88 (22%) of the subjects. The distribution of ApoE genotype was marginally different between subjects with MRI-detected stroke compared with those without. Further analysis revealed that the co-occurrence of cerebrovascular disease and ApoE4 was associated with significantly greater brain atrophy and WMH than either ApoE4 or cerebrovascular disease alone. Similar relations were seen for coronary heart disease and peripheral arterial disease. Conclusions - We conclude that ApoE4 enhances the extent of brain abnormalities in the presence of various vascular diseases. We speculate that this effect may be mediated by an increased susceptibility to brain injury or impaired repair mechanisms associated with ApoE4.

Original languageEnglish (US)
Pages (from-to)1548-1553
Number of pages6
JournalStroke
Volume30
Issue number8
StatePublished - Aug 1999
Externally publishedYes

Fingerprint

Apolipoprotein E4
National Heart, Lung, and Blood Institute (U.S.)
Twin Studies
Vascular Diseases
Genotype
Brain
Stroke
Cerebrovascular Disorders
Apolipoproteins E
Coronary Disease
Peripheral Arterial Disease
Atrophy
Cardiovascular Diseases
Independent Living

Keywords

  • Apolipoproteins
  • Brain injuries
  • Cerebrovascular disorders
  • Epidemiology
  • Magnetic resonance imaging

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Neuroscience(all)

Cite this

DeCarli, C., Reed, T., Miller, B. L., Wolf, P. A., Swan, G. E., & Carmelli, D. (1999). Impact of apolipoprotein E ε4 and vascular disease on brain morphology in men from the NHLBI twin study. Stroke, 30(8), 1548-1553.

Impact of apolipoprotein E ε4 and vascular disease on brain morphology in men from the NHLBI twin study. / DeCarli, Charles; Reed, T.; Miller, B. L.; Wolf, P. A.; Swan, G. E.; Carmelli, D.

In: Stroke, Vol. 30, No. 8, 08.1999, p. 1548-1553.

Research output: Contribution to journalArticle

DeCarli, C, Reed, T, Miller, BL, Wolf, PA, Swan, GE & Carmelli, D 1999, 'Impact of apolipoprotein E ε4 and vascular disease on brain morphology in men from the NHLBI twin study', Stroke, vol. 30, no. 8, pp. 1548-1553.
DeCarli C, Reed T, Miller BL, Wolf PA, Swan GE, Carmelli D. Impact of apolipoprotein E ε4 and vascular disease on brain morphology in men from the NHLBI twin study. Stroke. 1999 Aug;30(8):1548-1553.
DeCarli, Charles ; Reed, T. ; Miller, B. L. ; Wolf, P. A. ; Swan, G. E. ; Carmelli, D. / Impact of apolipoprotein E ε4 and vascular disease on brain morphology in men from the NHLBI twin study. In: Stroke. 1999 ; Vol. 30, No. 8. pp. 1548-1553.
@article{dcb0f49fc97742ecaf401904f08a77be,
title = "Impact of apolipoprotein E ε4 and vascular disease on brain morphology in men from the NHLBI twin study",
abstract = "Background and Purpose - Apolipoprotein E ε4 genotype (ApoE4) has been associated with increased risk for cardiovascular disease morbidity or mortality. This appears to be mediated by an ApoE4-related increase in cardiovascular atherosclerosis. Given the similarities between risk factors for heart disease and risk factors for stroke, a positive association between ApoE4 and stroke would be expected. Since age-related brain atrophy and the extent of white matter hyperintensities (WMH) share similar risk factors, we examined the combined effect of ApoE4 and history of vascular disease on brain volume, WMH, and MRI evidence of stroke. Methods - Subjects were the surviving members of the National Heart, Lung, and Blood Institute Twin Study. This is a longitudinal study of the effects of cardiovascular disease risk factors in community-dwelling male veterans. The fourth and final examination of this cohort included cerebral MRI and was completed in 1997. Apolipoprotein E (ApoE) genotype, quantitative measures of brain volume, WMH, and the presence of stroke on MRI were obtained from the 396 participants in the final examination. The presence or absence of a history of coronary heart disease, cerebrovascular disease, peripheral arterial disease, and ApoE genotype were determined for each subject. Results - Of the 396 men, 88 (22{\%}) had at least 1 ApoE4 allele. ApoE4 was not associated with differences in age or education. While the prevalence of vascular disease was generally greater in the ApoE4 group, this was only significant for coronary heart disease (29.8{\%} in subjects without ApoE4 versus 40.7{\%} in subject with ApoE4; P=0.03). ApoEA subjects had significantly smaller brain volumes (942.4±34.5 versus 952.2 ± 40.1 cm3; P= 0.02). MRI evidence of stroke was detected in 88 (22{\%}) of the subjects. The distribution of ApoE genotype was marginally different between subjects with MRI-detected stroke compared with those without. Further analysis revealed that the co-occurrence of cerebrovascular disease and ApoE4 was associated with significantly greater brain atrophy and WMH than either ApoE4 or cerebrovascular disease alone. Similar relations were seen for coronary heart disease and peripheral arterial disease. Conclusions - We conclude that ApoE4 enhances the extent of brain abnormalities in the presence of various vascular diseases. We speculate that this effect may be mediated by an increased susceptibility to brain injury or impaired repair mechanisms associated with ApoE4.",
keywords = "Apolipoproteins, Brain injuries, Cerebrovascular disorders, Epidemiology, Magnetic resonance imaging",
author = "Charles DeCarli and T. Reed and Miller, {B. L.} and Wolf, {P. A.} and Swan, {G. E.} and D. Carmelli",
year = "1999",
month = "8",
language = "English (US)",
volume = "30",
pages = "1548--1553",
journal = "Stroke",
issn = "0039-2499",
publisher = "Lippincott Williams and Wilkins",
number = "8",

}

TY - JOUR

T1 - Impact of apolipoprotein E ε4 and vascular disease on brain morphology in men from the NHLBI twin study

AU - DeCarli, Charles

AU - Reed, T.

AU - Miller, B. L.

AU - Wolf, P. A.

AU - Swan, G. E.

AU - Carmelli, D.

PY - 1999/8

Y1 - 1999/8

N2 - Background and Purpose - Apolipoprotein E ε4 genotype (ApoE4) has been associated with increased risk for cardiovascular disease morbidity or mortality. This appears to be mediated by an ApoE4-related increase in cardiovascular atherosclerosis. Given the similarities between risk factors for heart disease and risk factors for stroke, a positive association between ApoE4 and stroke would be expected. Since age-related brain atrophy and the extent of white matter hyperintensities (WMH) share similar risk factors, we examined the combined effect of ApoE4 and history of vascular disease on brain volume, WMH, and MRI evidence of stroke. Methods - Subjects were the surviving members of the National Heart, Lung, and Blood Institute Twin Study. This is a longitudinal study of the effects of cardiovascular disease risk factors in community-dwelling male veterans. The fourth and final examination of this cohort included cerebral MRI and was completed in 1997. Apolipoprotein E (ApoE) genotype, quantitative measures of brain volume, WMH, and the presence of stroke on MRI were obtained from the 396 participants in the final examination. The presence or absence of a history of coronary heart disease, cerebrovascular disease, peripheral arterial disease, and ApoE genotype were determined for each subject. Results - Of the 396 men, 88 (22%) had at least 1 ApoE4 allele. ApoE4 was not associated with differences in age or education. While the prevalence of vascular disease was generally greater in the ApoE4 group, this was only significant for coronary heart disease (29.8% in subjects without ApoE4 versus 40.7% in subject with ApoE4; P=0.03). ApoEA subjects had significantly smaller brain volumes (942.4±34.5 versus 952.2 ± 40.1 cm3; P= 0.02). MRI evidence of stroke was detected in 88 (22%) of the subjects. The distribution of ApoE genotype was marginally different between subjects with MRI-detected stroke compared with those without. Further analysis revealed that the co-occurrence of cerebrovascular disease and ApoE4 was associated with significantly greater brain atrophy and WMH than either ApoE4 or cerebrovascular disease alone. Similar relations were seen for coronary heart disease and peripheral arterial disease. Conclusions - We conclude that ApoE4 enhances the extent of brain abnormalities in the presence of various vascular diseases. We speculate that this effect may be mediated by an increased susceptibility to brain injury or impaired repair mechanisms associated with ApoE4.

AB - Background and Purpose - Apolipoprotein E ε4 genotype (ApoE4) has been associated with increased risk for cardiovascular disease morbidity or mortality. This appears to be mediated by an ApoE4-related increase in cardiovascular atherosclerosis. Given the similarities between risk factors for heart disease and risk factors for stroke, a positive association between ApoE4 and stroke would be expected. Since age-related brain atrophy and the extent of white matter hyperintensities (WMH) share similar risk factors, we examined the combined effect of ApoE4 and history of vascular disease on brain volume, WMH, and MRI evidence of stroke. Methods - Subjects were the surviving members of the National Heart, Lung, and Blood Institute Twin Study. This is a longitudinal study of the effects of cardiovascular disease risk factors in community-dwelling male veterans. The fourth and final examination of this cohort included cerebral MRI and was completed in 1997. Apolipoprotein E (ApoE) genotype, quantitative measures of brain volume, WMH, and the presence of stroke on MRI were obtained from the 396 participants in the final examination. The presence or absence of a history of coronary heart disease, cerebrovascular disease, peripheral arterial disease, and ApoE genotype were determined for each subject. Results - Of the 396 men, 88 (22%) had at least 1 ApoE4 allele. ApoE4 was not associated with differences in age or education. While the prevalence of vascular disease was generally greater in the ApoE4 group, this was only significant for coronary heart disease (29.8% in subjects without ApoE4 versus 40.7% in subject with ApoE4; P=0.03). ApoEA subjects had significantly smaller brain volumes (942.4±34.5 versus 952.2 ± 40.1 cm3; P= 0.02). MRI evidence of stroke was detected in 88 (22%) of the subjects. The distribution of ApoE genotype was marginally different between subjects with MRI-detected stroke compared with those without. Further analysis revealed that the co-occurrence of cerebrovascular disease and ApoE4 was associated with significantly greater brain atrophy and WMH than either ApoE4 or cerebrovascular disease alone. Similar relations were seen for coronary heart disease and peripheral arterial disease. Conclusions - We conclude that ApoE4 enhances the extent of brain abnormalities in the presence of various vascular diseases. We speculate that this effect may be mediated by an increased susceptibility to brain injury or impaired repair mechanisms associated with ApoE4.

KW - Apolipoproteins

KW - Brain injuries

KW - Cerebrovascular disorders

KW - Epidemiology

KW - Magnetic resonance imaging

UR - http://www.scopus.com/inward/record.url?scp=0032813761&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032813761&partnerID=8YFLogxK

M3 - Article

C2 - 10436099

AN - SCOPUS:0032813761

VL - 30

SP - 1548

EP - 1553

JO - Stroke

JF - Stroke

SN - 0039-2499

IS - 8

ER -